Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

Type Implementing Regulation

Publication 2025-04-22

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The [ova] ⁽²⁾ [embryos] ⁽²⁾ described in Part I: II.1.2. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team ⁽³⁾ described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC ⁽⁴⁾ and was subject to inspection by an official veterinarian at least once every calendar year; II.1.3. were [collected] ⁽²⁾ [produced] ⁽²⁾, processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC; II.1.4. were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection; II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in point II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled; II.1.6. come from donor mares which: II.1.6.1. were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC ⁽⁵⁾, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; ⁽²⁾ either [II.1.6.2. originated from a country of export which was on the day of collection free from vesicular stomatitis (VS) for a period of at least 6 months from that date;] ⁽²⁾ or [II.1.6.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE on a blood sample taken on … ⁽⁶⁾ within 30 days prior to the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ either [II.1.6.3. during a period of the past 30 days prior to the date of the collection were located in holdings under veterinary supervision which fulfilled from the day of the collection of the [ova] ⁽²⁾/ [embryos] ⁽²⁾ until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ or [II.1.6.3. in the case of frozen [ova] ⁽²⁾ [embryos] ⁽²⁾, during a period of the past 30 days prior to the date of the collection were kept in holdings under veterinary supervision which fulfilled, from the day of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ until the end of the period of 30 days mandatory storage at approved premises, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ either [II.1.6.3.1. following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae, — from vesicular stomatitis for a period of at least 6 months from the last recorded case, — from rabies for a period of at least one month from the last recorded case, — from anthrax for a period of at least 15 days from the last recorded case,] ⁽²⁾ or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the premises disinfected, the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or a period of at least 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.1.6.4. during a period of the past 30 days prior to the collection the [ova] ⁽²⁾ [embryos] ⁽²⁾ were kept in holdings in which none of the equidae has shown clinical signs of contagious equine metritis for a period of at least 60 days; II.1.6.5. were not used for natural breeding during a period of at least 30 days prior to the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and between the date of the first samples referred to in points II.1.6.6.1 and II.1.6.6.2 and the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾; II.1.6.6. have undergone the tests, which meet at least the requirements of the relevant Chapters of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 ⁽⁷⁾, as follows: ⁽⁸⁾ [II.1.6.6.1. for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result carried out on a blood sample taken on … ⁽⁶⁾, being not less than 14 days following the date of commencement of the period referred to in point II.1.6.5 and not more than 90 days prior to the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ intended for imports into the Union;] II.1.6.6.2. for contagious equine metritis (CEM), an agent identification test carried out with a negative result on at least two specimens (swabs) taken during the period referred to in point II.1.6.5 from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare: ⁽²⁾ either [II.1.6.6.2.1. on two occasions with an interval of not less than 7 days on … ⁽⁶⁾ and on … ⁽⁶⁾, in the case of isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport,] ⁽²⁾ and/or [II.1.6.6.2.2. on one occasion on … ⁽⁶⁾, in the case of detection of the genome of Taylorella equigenitalis by a polymerase chain reaction (PCR) or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal,] The samples referred to in points II.1.6.6.2.1 and II.1.6.6.2.2 were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor mare and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory. II.1.6.7. to the best of my knowledge and as far as I could ascertain, were not in contact with equidae suffering from an infectious or contagious disease during the period of 15 days immediately preceding the collection; II.1.6.8. on the day of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ did not show clinical signs of an infectious or contagious disease; II.1.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo [collection] ⁽²⁾ [production] ⁽²⁾ team described in box I.11 was approved by the competent authority of the exporting country; II.1.8. were processed and stored under approved conditions for a period of at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾, and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2. The embryos described in Part I were conceived [by artificial insemination] ⁽¹⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC ⁽⁹⁾ and located respectively in a Member State of the Union or in a third country or parts of the territory of a third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. ^{(10) (11)} ⁽¹²⁾ [II.3. The ova used for in vitro production of the embryos described in Part I comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate.] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment of were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 the table in Part 1 of that Annex. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 14.9.1992, p. 54). ⁽⁵⁾ Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1). ⁽⁶⁾ Insert date. (follow Guidance in Part II of the Notes). ⁽⁷⁾ Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1). ⁽⁸⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equidae which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos have were introduced into Iceland from outside prior to and during the period the ova or embryos were collected and the semen was used for fertilisation. ⁽⁹⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex XII to Commission Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State. ⁽¹⁰⁾ Entry into the Union of equine semen is authorised from third countries listed in column 2 of the table in Part 1 of Annex I to Commission Implementing Regulation (EU) 2018/659 provided that the semen was collected in the part of the territory of the third country detailed in column 4 of the table in Part 1 of that Annex from a donor stallion of the category of equidae positively indicated in column 11, 12 or 13 of the table in Part 1 of that Annex. ⁽¹¹⁾ Does not apply to ova. ⁽¹²⁾ Delete if none of the embryos in the consignment was produced by in vitro fertilisation of ova.

I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The [ova] ⁽²⁾ [embryos] ⁽²⁾ described in Part I: II.1.2. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team ⁽³⁾ described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC ⁽⁴⁾ and was subject to inspection by an official veterinarian at least once every calendar year; II.1.3. were [collected] ⁽²⁾ [produced] ⁽²⁾, processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC; II.1.4. were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection; II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in point II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled; II.1.6. come from donor mares which: II.1.6.1. were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC ⁽⁵⁾, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; ⁽²⁾ either [II.1.6.2. originated from a country of export which was on the day of collection free from vesicular stomatitis (VS) for a period of at least 6 months from that date;] ⁽²⁾ or [II.1.6.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE on a blood sample taken on … ⁽⁶⁾ within 30 days prior to the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ either [II.1.6.3. during a period of the past 30 days prior to the date of the collection were located in holdings under veterinary supervision which fulfilled from the day of the collection of the [ova] ⁽²⁾/ [embryos] ⁽²⁾ until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ or [II.1.6.3. in the case of frozen [ova] ⁽²⁾ [embryos] ⁽²⁾, during a period of the past 30 days prior to the date of the collection were kept in holdings under veterinary supervision which fulfilled, from the day of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ until the end of the period of 30 days mandatory storage at approved premises, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ either [II.1.6.3.1. following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae, — from vesicular stomatitis for a period of at least 6 months from the last recorded case, — from rabies for a period of at least one month from the last recorded case, — from anthrax for a period of at least 15 days from the last recorded case,] ⁽²⁾ or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the premises disinfected, the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or a period of at least 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.1.6.4. during a period of the past 30 days prior to the collection the [ova] ⁽²⁾ [embryos] ⁽²⁾ were kept in holdings in which none of the equidae has shown clinical signs of contagious equine metritis for a period of at least 60 days; II.1.6.5. were not used for natural breeding during a period of at least 30 days prior to the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and between the date of the first samples referred to in points II.1.6.6.1 and II.1.6.6.2 and the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾; II.1.6.6. have undergone the tests, which meet at least the requirements of the relevant Chapters of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 ⁽⁷⁾, as follows: ⁽⁸⁾ [II.1.6.6.1. for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result carried out on a blood sample taken on … ⁽⁶⁾, being not less than 14 days following the date of commencement of the period referred to in point II.1.6.5 and not more than 90 days prior to the date of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ intended for imports into the Union;] II.1.6.6.2. for contagious equine metritis (CEM), an agent identification test carried out with a negative result on at least two specimens (swabs) taken during the period referred to in point II.1.6.5 from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare: ⁽²⁾ either [II.1.6.6.2.1. on two occasions with an interval of not less than 7 days on … ⁽⁶⁾ and on … ⁽⁶⁾, in the case of isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport,] ⁽²⁾ and/or [II.1.6.6.2.2. on one occasion on … ⁽⁶⁾, in the case of detection of the genome of Taylorella equigenitalis by a polymerase chain reaction (PCR) or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal,] The samples referred to in points II.1.6.6.2.1 and II.1.6.6.2.2 were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor mare and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory. II.1.6.7. to the best of my knowledge and as far as I could ascertain, were not in contact with equidae suffering from an infectious or contagious disease during the period of 15 days immediately preceding the collection; II.1.6.8. on the day of the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ did not show clinical signs of an infectious or contagious disease; II.1.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo [collection] ⁽²⁾ [production] ⁽²⁾ team described in box I.11 was approved by the competent authority of the exporting country; II.1.8. were processed and stored under approved conditions for a period of at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾, and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2. The embryos described in Part I were conceived [by artificial insemination] ⁽¹⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC ⁽⁹⁾ and located respectively in a Member State of the Union or in a third country or parts of the territory of a third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. ^{(10) (11)} ⁽¹²⁾ [II.3. The ova used for in vitro production of the embryos described in Part I comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate.] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment of were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 the table in Part 1 of that Annex. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 14.9.1992, p. 54). ⁽⁵⁾ Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1). ⁽⁶⁾ Insert date. (follow Guidance in Part II of the Notes). ⁽⁷⁾ Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1). ⁽⁸⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equidae which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos have were introduced into Iceland from outside prior to and during the period the ova or embryos were collected and the semen was used for fertilisation. ⁽⁹⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex XII to Commission Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State. ⁽¹⁰⁾ Entry into the Union of equine semen is authorised from third countries listed in column 2 of the table in Part 1 of Annex I to Commission Implementing Regulation (EU) 2018/659 provided that the semen was collected in the part of the territory of the third country detailed in column 4 of the table in Part 1 of that Annex from a donor stallion of the category of equidae positively indicated in column 11, 12 or 13 of the table in Part 1 of that Annex. ⁽¹¹⁾ Does not apply to ova. ⁽¹²⁾ Delete if none of the embryos in the consignment was produced by in vitro fertilisation of ova.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 65 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF OOCYTES AND EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “EQUI-OOCYTES-EMB-C-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-OOCYTES-EMB-C-ENTRY	Certificate model EQUI-OOCYTES-EMB-C-ENTRY	Certificate model EQUI-OOCYTES-EMB-C-ENTRY	Certificate model EQUI-OOCYTES-EMB-C-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The [ova] ⁽²⁾ [embryos] ⁽²⁾ described in Part I: II.1.2. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team ⁽³⁾ described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC and was subject to inspection by an official veterinarian at least once every calendar year; II.1.3. were [collected] ⁽²⁾ [produced] ⁽²⁾, processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC; II.1.4. were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection; II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in box II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled; II.1.6. come from donor mares which: II.1.6.1. were continuously resident for 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC ⁽⁴⁾, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for at least 2 years, — free from glanders and dourine for at least 6 months; ⁽²⁾ either [II.1.6.2. originated from a country of export which was on the day of collection free of vesicular stomatitis for at least 6 months;] ⁽²⁾ or [II.1.6.2. were tested by a virus neutralisation test for vesicular stomatitis on a blood sample taken on … ⁽⁵⁾ within 30 days prior to collection, with negative result at a serum dilution of 1 in 12;] ⁽²⁾ either [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ or [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ until, in the case of frozen [ova] ⁽²⁾ [embryos] ⁽²⁾, the period of 30 days mandatory storage at approved premises elapsed, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular:] ⁽²⁾ either [II.1.6.3.1. following a case of a disease mentioned below not all the animals of species susceptible to the disease located on the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae; — from vesicular stomatitis for at least 6 months from the last recorded case, — from rabies for at least one month from the last recorded case, — from anthrax for at least 15 days from the last recorded case,] ⁽²⁾ or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species susceptible to the disease located in the holding have been slaughtered or killed and the premises disinfected, the holding has been free for at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.1.6.4. during the past 30 days prior to collection have been kept in holdings each of them having been free from clinical signs of contagious equine metritis for at least 60 days; II.1.6.5. have not been used for natural breeding during at least 30 days prior to the date of collection of ova or embryos and between the date of the first samples referred to in points II.1.6.6 and II.1.6.7 and the date of the collection of ova and embryos; II.1.6.6. have been subjected with negative result to an agar-gel immuno-diffusion test (Coggins test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on … ⁽⁵⁾ being during the past 30 days prior to the date of the first collection of ova or embryos and not more than 90 days before the ova or embryos were collected ⁽⁶⁾; II.1.6.7. have been subjected to an agent identification test for contagious equine metritis by isolation of Taylorella equigenitalis after a cultivation of 7 to 14 days carried out with negative results in each case on samples taken during the past 30 days prior to the date of the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and clitoral sinuses on two consecutives oestrus periods on … ⁽⁵⁾ and on … ⁽⁵⁾, and on an additional culture specimen taken during one of the oestrus periods from the endometrial cervix on … ⁽⁵⁾; II.1.6.8. to the best of my knowledge and as far as I could ascertain, have not been in contact with equidae suffering from an infectious or contagious disease during the 15 days immediately preceding the collection; II.1.6.9. have on the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ not shown clinical signs of an infectious or contagious disease; II.1.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo [collection] ⁽²⁾ [production] ⁽²⁾ team described in box I.11 was approved by the competent authority of the exporting country; II.1.8. were processed and stored under approved conditions for at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾, and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2. The embryos described in Part I were conceived [by artificial insemination] ⁽²⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC and located respectively in a Member State of the European Union or in a third country or parts of the territory of third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. ⁽⁷⁾⁽⁸⁾; II.3. The ova used for in vitro production of the embryos described above comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate ⁽²⁾. Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Council Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into the Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 of the table in Part 1 of that Annex. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ OJ L 192, 23.7.2010, p. 1. ⁽⁵⁾ Insert date. ⁽⁶⁾ The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, oocytes and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁷⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Part 1 of Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State. ⁽⁸⁾ Does not apply to ova.

I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The [ova] ⁽²⁾ [embryos] ⁽²⁾ described in Part I: II.1.2. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team ⁽³⁾ described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC and was subject to inspection by an official veterinarian at least once every calendar year; II.1.3. were [collected] ⁽²⁾ [produced] ⁽²⁾, processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC; II.1.4. were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection; II.1.5. were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in box II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled; II.1.6. come from donor mares which: II.1.6.1. were continuously resident for 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC ⁽⁴⁾, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for at least 2 years, — free from glanders and dourine for at least 6 months; ⁽²⁾ either [II.1.6.2. originated from a country of export which was on the day of collection free of vesicular stomatitis for at least 6 months;] ⁽²⁾ or [II.1.6.2. were tested by a virus neutralisation test for vesicular stomatitis on a blood sample taken on … ⁽⁵⁾ within 30 days prior to collection, with negative result at a serum dilution of 1 in 12;] ⁽²⁾ either [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:] ⁽²⁾ or [II.1.6.3. during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ until, in the case of frozen [ova] ⁽²⁾ [embryos] ⁽²⁾, the period of 30 days mandatory storage at approved premises elapsed, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular:] ⁽²⁾ either [II.1.6.3.1. following a case of a disease mentioned below not all the animals of species susceptible to the disease located on the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae; — from vesicular stomatitis for at least 6 months from the last recorded case, — from rabies for at least one month from the last recorded case, — from anthrax for at least 15 days from the last recorded case,] ⁽²⁾ or [II.1.6.3.1. following a case of a disease mentioned below all the animals of species susceptible to the disease located in the holding have been slaughtered or killed and the premises disinfected, the holding has been free for at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.1.6.4. during the past 30 days prior to collection have been kept in holdings each of them having been free from clinical signs of contagious equine metritis for at least 60 days; II.1.6.5. have not been used for natural breeding during at least 30 days prior to the date of collection of ova or embryos and between the date of the first samples referred to in points II.1.6.6 and II.1.6.7 and the date of the collection of ova and embryos; II.1.6.6. have been subjected with negative result to an agar-gel immuno-diffusion test (Coggins test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on … ⁽⁵⁾ being during the past 30 days prior to the date of the first collection of ova or embryos and not more than 90 days before the ova or embryos were collected ⁽⁶⁾; II.1.6.7. have been subjected to an agent identification test for contagious equine metritis by isolation of Taylorella equigenitalis after a cultivation of 7 to 14 days carried out with negative results in each case on samples taken during the past 30 days prior to the date of the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and clitoral sinuses on two consecutives oestrus periods on … ⁽⁵⁾ and on … ⁽⁵⁾, and on an additional culture specimen taken during one of the oestrus periods from the endometrial cervix on … ⁽⁵⁾; II.1.6.8. to the best of my knowledge and as far as I could ascertain, have not been in contact with equidae suffering from an infectious or contagious disease during the 15 days immediately preceding the collection; II.1.6.9. have on the day of collection of [ova] ⁽²⁾ [embryos] ⁽²⁾ not shown clinical signs of an infectious or contagious disease; II.1.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo [collection] ⁽²⁾ [production] ⁽²⁾ team described in box I.11 was approved by the competent authority of the exporting country; II.1.8. were processed and stored under approved conditions for at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾, and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2. The embryos described in Part I were conceived [by artificial insemination] ⁽²⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC and located respectively in a Member State of the European Union or in a third country or parts of the territory of third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. ⁽⁷⁾⁽⁸⁾; II.3. The ova used for in vitro production of the embryos described above comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate ⁽²⁾. Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Council Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into the Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 of the table in Part 1 of that Annex. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ OJ L 192, 23.7.2010, p. 1. ⁽⁵⁾ Insert date. ⁽⁶⁾ The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, oocytes and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁷⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Part 1 of Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State. ⁽⁸⁾ Does not apply to ova.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 66 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

— semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

— stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

— stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

— oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

— stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

(MODEL “EQUI-GP-PROCESSING-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species
Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-GP-PROCESSING-ENTRY	Certificate model EQUI-GP-PROCESSING-ENTRY	Certificate model EQUI-GP-PROCESSING-ENTRY	Certificate model EQUI-GP-PROCESSING-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify, that all: II.1. The germinal product processing establishment ⁽¹⁾ described in box I.11 at which the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ [micromanipulated embryos] ⁽²⁾ to be dispatched to the Union was/were processed and stored: II.1.1. is located in a third country or territory, or zone thereof: II.1.1.1. authorised for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404; II.1.1.2. free from African horse sickness for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch in accordance with Article 22(2), point (a), of Commission Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch in accordance with Article 22(4), point (b), of that Regulation; II.1.1.3. where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch; II.1.2. is an establishment, where: ⁽²⁾ either [II.1.2.1. infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.1. infection with Burkholderia mallei (glanders) was not reported for at least six months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽²⁾ either [II.1.2.2. dourine was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.2. dourine was not reported for at least 6 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽²⁾ either [II.1.2.3. surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.3. surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.] II.1.3. is approved and listed by the competent authority of the third country or territory; II.1.4. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.] II.2. The [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ described in Part I is/are intended for artificial reproduction, and: II.2.1. has/have been [collected] ⁽²⁾ [produced] ⁽²⁾, [processed] ⁽²⁾ [stored] ⁽²⁾ [in a semen collection centre] ^{(2) (3)} [by an embryo collection team] ^{(2) (3)} [by an embryo production team] ^{(2) (3)} and [processed] ⁽²⁾ [stored] ⁽²⁾ in a germinal product processing establishment ⁽³⁾ [and stored in a germinal product storage centre] ^{(2) (3)} complying with requirements as regards responsibilities, operational procedures, facilities and equipment set out in [Part 1] ⁽²⁾ [Part 2] ⁽²⁾ [Part 3] ⁽²⁾ [Part 4] ⁽²⁾ [Part 5] ⁽²⁾ of Annex I to Delegated Regulation (EU) 2020/686, and: ⁽²⁾ either [located in the third country or territory of dispatch to the Union;] ^{(2) (4)} and/or [located in …, and has/have been introduced into the third country of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of equine animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;] II.2.2. was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in: ⁽²⁾ either [Model EQUI-SEM-A-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-B-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-C-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-D-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-A-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-B-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-C-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-GP-PROCESSING-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-GP-STORAGE-ENTRY ⁽⁵⁾;] II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686; II.2.4. is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.2.5. is/are transported in a container which: II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product processing establishment under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(2) (6)} [II.2.5.3. has been filled in with a cryogenic agent which has not been previously used for other products;] ^{(2) (7)} [II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed; II.2.7. is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] Notes This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of equine animals, including when the Union is not the final destination of the semen, oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes or embryos. Box reference I.17 : “Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. Identification mark: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ Only a third country or territory, or zone thereof listed in Annex XII to Implementing Regulation (EU) 2021/404 and Member States. ⁽⁵⁾ The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate. ⁽⁶⁾ Applicable for frozen semen, oocytes or embryos. ⁽⁷⁾ Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine animals are placed and transported in one container.

I, the undersigned official veterinarian, hereby certify, that all: II.1. The germinal product processing establishment ⁽¹⁾ described in box I.11 at which the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ [micromanipulated embryos] ⁽²⁾ to be dispatched to the Union was/were processed and stored: II.1.1. is located in a third country or territory, or zone thereof: II.1.1.1. authorised for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404; II.1.1.2. free from African horse sickness for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch in accordance with Article 22(2), point (a), of Commission Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch in accordance with Article 22(4), point (b), of that Regulation; II.1.1.3. where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch; II.1.2. is an establishment, where: ⁽²⁾ either [II.1.2.1. infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.1. infection with Burkholderia mallei (glanders) was not reported for at least six months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽²⁾ either [II.1.2.2. dourine was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.2. dourine was not reported for at least 6 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽²⁾ either [II.1.2.3. surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ or [II.1.2.3. surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.] II.1.3. is approved and listed by the competent authority of the third country or territory; II.1.4. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.] II.2. The [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ described in Part I is/are intended for artificial reproduction, and: II.2.1. has/have been [collected] ⁽²⁾ [produced] ⁽²⁾, [processed] ⁽²⁾ [stored] ⁽²⁾ [in a semen collection centre] ^{(2) (3)} [by an embryo collection team] ^{(2) (3)} [by an embryo production team] ^{(2) (3)} and [processed] ⁽²⁾ [stored] ⁽²⁾ in a germinal product processing establishment ⁽³⁾ [and stored in a germinal product storage centre] ^{(2) (3)} complying with requirements as regards responsibilities, operational procedures, facilities and equipment set out in [Part 1] ⁽²⁾ [Part 2] ⁽²⁾ [Part 3] ⁽²⁾ [Part 4] ⁽²⁾ [Part 5] ⁽²⁾ of Annex I to Delegated Regulation (EU) 2020/686, and: ⁽²⁾ either [located in the third country or territory of dispatch to the Union;] ^{(2) (4)} and/or [located in …, and has/have been introduced into the third country of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of equine animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;] II.2.2. was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in: ⁽²⁾ either [Model EQUI-SEM-A-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-B-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-C-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-SEM-D-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-A-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-B-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-OOCYTES-EMB-C-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-GP-PROCESSING-ENTRY ⁽⁵⁾;] ⁽²⁾ and/or [Model EQUI-GP-STORAGE-ENTRY ⁽⁵⁾;] II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686; II.2.4. is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.2.5. is/are transported in a container which: II.2.5.1. was sealed and numbered prior to the dispatch from the germinal product processing establishment under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(2) (6)} [II.2.5.3. has been filled in with a cryogenic agent which has not been previously used for other products;] ^{(2) (7)} [II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed; II.2.7. is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] Notes This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of equine animals, including when the Union is not the final destination of the semen, oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes or embryos. Box reference I.17 : “Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. Identification mark: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽⁴⁾ Only a third country or territory, or zone thereof listed in Annex XII to Implementing Regulation (EU) 2021/404 and Member States. ⁽⁵⁾ The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate. ⁽⁶⁾ Applicable for frozen semen, oocytes or embryos. ⁽⁷⁾ Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine animals are placed and transported in one container.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 67 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STORAGE CENTRE:

— semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

— stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

— stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

— oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

— stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

(MODEL “EQUI-GP-STORAGE-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-GP-STORAGE-ENTRY	Certificate model EQUI-GP-STORAGE-ENTRY	Certificate model EQUI-GP-STORAGE-ENTRY	Certificate model EQUI-GP-STORAGE-ENTRY
	II. Health information	II.a	Certificate reference	II.b.	IMSOC reference

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.